home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Zoetis (NY:ZTS)

74.76 -0.72 (-0.95%)

Streaming Delayed Price Updated: 12:05 PM EDT, May 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

25 26 Next >

3 Healthcare Stocks to Watch As the Industry Evolves ↗

March 31, 2023

Healthcare stocks are often considered a safe investment due to the consistent demand for medical products and services.

Via InvestorPlace

Zoetis to Host Webcast and Conference Call on First Quarter 2023 Financial Results

March 30, 2023

From Zoetis Inc.

Via Business Wire

Zoetis Stock Sees IBD Relative Strength Rating Improve To 73 ↗

March 27, 2023

Zoetis stock had its Relative Strength Rating upgraded to 73 Monday -- a nice improvement, but still shy of the 80-plus score you look for.

Via Investor's Business Daily

$100 Invested In Zoetis 5 Years Ago Would Be Worth This Much Today ↗

March 20, 2023

Via Benzinga

Zoetis Named One of the World’s Most Ethical Companies by Ethisphere

March 13, 2023

From Zoetis Inc.

Via Business Wire

$100 Invested In Zoetis 5 Years Ago Would Be Worth This Much Today ↗

March 09, 2023

Via Benzinga

This Favorable Sign Appears On Zoetis's Chart ↗

March 03, 2023

Via Benzinga

Zoetis to Participate in the TD Cowen Health Care Conference

March 03, 2023

From Zoetis Inc.

Via Business Wire

Zoetis Secures $15.3 Million Grant to Advance Sustainable Livestock Production and Improve Livelihoods in Sub-Saharan Africa

March 01, 2023

From Zoetis Inc.

Via Business Wire

Zoetis Stock Shows Rising Relative Strength Upgrades ↗

February 17, 2023

Zoetis shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81.

Via Investor's Business Daily

Zoetis (ZTS) Q4 2022 Earnings Call Transcript ↗

February 14, 2023

ZTS earnings call for the period ending December 31, 2022.

Via The Motley Fool

Zoetis Snags A Quarterly Sales Beat And Issues A Strong 2023 Outlook ↗

February 14, 2023

Zoetis posted better-than-expected sales Tuesday while earnings met forecasts.

Via Investor's Business Daily

Zoetis to Participate in the Bank of America Securities 2023 Animal Health Summit

February 28, 2023

From Zoetis Inc.

Via Business Wire

Arista Networks, Zoetis And This Airline Stock On CNBC's 'Final Trades' ↗

February 27, 2023

On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named Zoetis Inc (NYSE: ZTS) as her

Via Benzinga

3 Stocks to Avoid This Week ↗

February 21, 2023

These investments seem pretty vulnerable right now.

Via The Motley Fool

MarketBeat Week in Review – 2/13 - 2/17

February 18, 2023

Retail sales were up but so was inflation which meant more volatility for stocks. Enjoy your holiday weekend and catch up on our most read stories this week

Via MarketBeat

Topics Economy

3 Stocks to Avoid This Week ↗

February 13, 2023

These investments seem pretty vulnerable right now.

Via The Motley Fool

Here's How Much $1000 Invested In Zoetis 10 Years Ago Would Be Worth Today ↗

January 19, 2023

Via Benzinga

Why Zoetis Stock Shot Almost 9% Higher This Week ↗

February 17, 2023

Robust net-income growth and better-than-expected guidance brought the bulls back to the animal health specialist.

Via The Motley Fool

Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead

February 16, 2023

Animal health company Zoetis is up 7.99% in the past week, after topping fourth-quarter views. Analysts see double-digit EPS growth in 2023 and 2024.

Via MarketBeat

Zoetis, NVIDIA And This Big US Bank Is 'Outperforming This Year': CNBC's 'Final Trades' ↗

February 15, 2023

On CNBC’s "Halftime Report Final Trades," Stephanie Link of Hightower said Zoetis Inc.

Via Benzinga

Avis Budget, Zoetis, Palantir Technologies And Other Big Stocks Moving Higher On Tuesday ↗

February 14, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Zoetis Posts Better Than Expected Q4 Earnings On Higher Companion Animal Products, Issues Upbeat Annual Guidance ↗

February 14, 2023

Via Benzinga

If You Invested $5,000 in Zoetis in 2013, This Is How Much You Would Have Today ↗

January 18, 2023

Your returns would be the cat's meow, to say the least.

Via The Motley Fool

3 Reasons to Buy Zoetis, and 1 Reason to Sell ↗

January 17, 2023

This stock is a proven long-term play, but it's struggling lately.

Via The Motley Fool

Zoetis Reports Fourth Quarter and Full Year 2022 Results

February 14, 2023

From Zoetis Inc.

Via Business Wire

Zoetis Declares Second Quarter 2023 Dividend

February 08, 2023

From Zoetis Inc.

Via Business Wire

4 Top Stocks With High Dividend Growth to Buy in 2023 and Hold Forever ↗

January 28, 2023

These businesses offer powerful passive income potential, growing their dividends between 178% and 481% over the last five years.

Via The Motley Fool

Zoetis, SL Green Realty, Abbott Laboratories And This Big Bank Reporting Earnings On Friday: CNBC's 'Final Trades' ↗

January 12, 2023

On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named Zoetis Inc.

Via Benzinga

Earnings Scheduled For February 14, 2023 ↗

February 14, 2023

Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com